Showing results (101-110 of 160) with videos related to
Sort By:
Pageof 16
Health Affairs (Project Hope)|July 9, 2008
The impact of pay-for-performance on health care quality in Massachusetts, 2001-2003Steven D Pearson, Eric C Schneider, Ken P Kleinman, et al.Journal of Managed Care & Specialty Pharmacy|August 29, 2020
The Effectiveness and Value of Oral Semaglutide for Type 2 Diabetes MellitusKatherine T Fazioli, David M Rind, Gregory F Guzauskas, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2021
The effectiveness and value of aducanumab for Alzheimer's diseasePatricia G Synnott, Melanie D Whittington, Grace A Lin, et al.Postgraduate Medicine|November 9, 2013
Evaluating the evidence on comparative effectiveness and value of management options for treatment-resistant depressionSarah K Emond, Daniel A Ollendorf, Jennifer A Colby, et al.Postgraduate Medicine|October 26, 2012
Management strategies for attention-deficit/hyperactivity disorder: a regional deliberation on the evidenceSarah K Emond, Daniel A Ollendorf, Jennifer A Colby, et al.Annals of Internal Medicine|August 30, 2016
Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection FractionAlexander T Sandhu, Daniel A Ollendorf, Richard H Chapman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancerC Daniel Mullins, Russ Montgomery, Amy P Abernethy, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 14, 2017
Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness researchKathryn A Phillips, Patricia A Deverka, Harold C Sox, et al.Journal of Managed Care & Specialty Pharmacy|April 28, 2021
The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitorsFoluso Agboola, David M Rind, Surrey M Walton, et al.Journal of Managed Care & Specialty Pharmacy|December 24, 2021
The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravisJeffrey A Tice, Daniel R Touchette, Pei-Wen Lien, et al.Pageof 16